Free Radical Biology and Medicine, 39, 34554
Rights and permissions About this article Cite this article Xie, Y., Choi, T
On the rarer but more serious front, GLP-1 RAs have been associated with increased risks of thyroid cancer and pancreatitis.7 9 Though uncommon, it's critical that you divulge any thyroid issues, pancreatic concerns, or family history of cancer to your doctor
This synergy aims to minimize drug toxicity while augmenting therapeutic efficacy in the treatment of cancer (Xiong et al., 2019
First, Alzheimers disease and other dementias are strongly linked to metabolic dysfunctionespecially insulin resistance in the brain, sometimes labeled type 3 diabetes. Second, a class of diabetes and weight-management medicines called GLP-1 receptor agonists (GLP-1 RAs) shows early but increasingly consistent signals that they may lower dementia risk in people with type 2 diabetes, and possibly slow specific biological changes of Alzheimers in small clinical trials